Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02180984 : The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED
PhasePhase 2
AgesMin: 18 Years Max: 55 Years
Inclusion Criteria:

- 18 to 55 years old

- Right handed

- Females

- BED diagnosis (EDE 16.0 - BED module) according to the DSM-5 criteria

- BMI ? 35kg/m2 and body weight ? 150kg

- Ability to write, read, and understand all elements of the study

- Safety laboratory blood work (fasting glucose, fasting glucose/insulin ratio, CBC,
and TSH) within normal range

- Informed consent signed.

Exclusion Criteria:

- Past history of head or eye injury or epilepsy

- Body metallic implants, pacemaker, claustrophobia and any other contraindication to
fMRI or rTMS;

- Current use of psychotropic drugs (except for antidepressants on a stable dose for at
least one month)

- Current use of any anti-obesity drug (three months washout period for any other

- Pregnancy or breastfeeding

- Diabetes Mellitus diagnosis

- Major psychiatric disorder requiring immediate treatment

- Substance dependence (SCID-I/P module for substance abuse and/or dependence applied
for those who disclose substance use at checklist, following the DSM-5 criteria)

- Individuals currently receiving any psychological therapy for their eating disorder

- Cushing's and Turner's syndrome.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557